Lupride Depot 3.75mg Injection contains leuprolide (leuprorelin), a long-acting gonadotropin-releasing hormone (GnRH) agonist used under medical supervision for hormone-dependent conditions. The medicine is commonly prescribed in conditions such as endometriosis, uterine fibroids, prostate cancer, and certain hormone-related disorders, depending on the specific formulation and local prescribing information.

Rather than simply treating symptoms, leuprolide works by changing the production of reproductive hormones. After an initial stimulation, continued GnRH activity suppresses pituitary gonadotropins and consequently reduces the production of sex hormones. This hormone-suppressing action makes leuprolide useful when estrogen- or testosterone-dependent disease activity needs to be controlled.

Because hormone suppression can produce significant effects throughout the body, Lupride Depot 3.75mg Injection should only be used when a qualified healthcare professional has prescribed it. A healthcare professional should also administer the depot injection according to the prescribed schedule.

How Lupride Depot 3.75mg Injection Works

The active ingredient, leuprolide, acts as a GnRH agonist. At the beginning of treatment, it can temporarily increase certain reproductive hormones. With continued exposure, however, it suppresses pituitary signaling and reduces the downstream production of sex hormones.

For endometriosis, reducing estrogen stimulation can help relieve pain and reduce endometriotic lesions. For uterine fibroids, hormonal suppression can help reduce bleeding-related problems and support preoperative management in appropriately selected patients. Leuprolide products are also used in prostate cancer to reduce androgen stimulation of hormone-sensitive cancer cells, although the exact approved indication depends on the particular product and formulation.

This mechanism explains why patients may notice changes such as hot flashes, menstrual changes, decreased libido, mood changes, or other hormonal effects during treatment.

Uses and Potential Benefits

Doctors may prescribe Lupride Depot 3.75mg Injection for hormone-dependent conditions. Product information from India lists uses including prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.

For endometriosis, leuprolide can reduce estrogen stimulation and may help control pelvic pain and disease activity. For fibroids, hormonal suppression may help reduce bleeding and improve anemia-related outcomes before surgery in appropriately selected patients. The U.S. prescribing information for the corresponding 3.75-mg leuprolide depot formulation specifically identifies endometriosis and preoperative hematologic improvement associated with uterine fibroids as indications.

The medicine does not work like a conventional painkiller. Its benefits develop through hormonal suppression, so patients should follow the complete treatment plan provided by their physician rather than stopping treatment when symptoms temporarily improve.

Dosage and Administration

The appropriate dose and treatment duration depend on the condition being treated, the patient’s age, medical history, and the specific product formulation. The 3.75-mg depot formulation is designed for administration by a healthcare professional.

For the U.S. LUPRON DEPOT 3.75-mg formulation, treatment for endometriosis uses one intramuscular injection every month, with an initial course of up to six injections. For uterine fibroids, the labeled regimen is one intramuscular injection every month for up to three months.

Patients should never change the injection interval, dose, or treatment duration on their own. Depot formulations with different strengths or release schedules are not automatically interchangeable. The U.S. prescribing information specifically warns against substituting the 3.75-mg monthly formulation with the 11.25-mg three-month formulation.

Related Product

Important Safety Information

Lupride Depot 3.75mg Injection can cause clinically important hormonal and systemic effects. Common adverse reactions reported with the corresponding 3.75-mg leuprolide depot formulation include hot flashes or sweating, headache or migraine, vaginitis, depression or emotional changes, pain, weight changes, nausea or vomiting, decreased libido, and dizziness.

Long-term hormone suppression can reduce bone mineral density. For endometriosis, the U.S. labeling limits total treatment with the 3.75-mg formulation and norethindrone add-back therapy to 12 months because of concerns regarding bone mineral density.

Patients should tell their doctor about previous allergic reactions, osteoporosis or fracture risk, seizures, cardiovascular problems, metabolic disorders, or other significant medical conditions. Serious hypersensitivity reactions, including anaphylaxis, have been reported. Severe cutaneous adverse reactions have also been reported, and patients should seek urgent medical attention if they develop serious skin reactions.

This medicine should not be used during pregnancy. The official prescribing information warns against use in patients who are pregnant or may be pregnant because GnRH agonist therapy can cause embryo-fetal harm.

Why Medical Supervision Matters

Lupride Depot 3.75mg Injection is not a routine self-care medicine. A healthcare professional must determine whether hormone suppression is appropriate and select the correct treatment schedule. Your clinician may monitor symptoms, hormonal response, bone health, blood counts, or other relevant clinical parameters depending on the condition being treated.

Patients should also tell their healthcare provider about all prescription medicines, over-the-counter medicines, and supplements they use. This helps the healthcare team identify potential treatment concerns and coordinate appropriate monitoring.

Storage and Handling

Store the product according to the manufacturer’s instructions and pharmacy requirements. Do not use an injection if the packaging is damaged, the product appears abnormal, or it has passed its expiry date. Preparation and administration should follow the product-specific instructions and should be performed by trained healthcare personnel.

Ordering Information

If your healthcare professional has prescribed Lupride Depot 3.75mg Injection, obtain it through a legitimate, licensed pharmacy and provide the required prescription. Because this is a prescription injection, do not purchase or use it solely on the basis of online product descriptions.

Before ordering, confirm the exact strength, formulation, manufacturer, and intended treatment schedule with your prescriber or pharmacist. A pharmacist can also help verify whether the product supplied matches your prescription.

Frequently Asked Questions

1. What is Lupride Depot 3.75mg Injection used for?

It contains leuprolide, a GnRH agonist. Depending on the specific product and country, leuprolide depot formulations are used for hormone-dependent conditions such as endometriosis, uterine fibroids, prostate cancer, and certain forms of early puberty.

2. How does Lupride Depot 3.75mg Injection work?

Leuprolide initially stimulates GnRH receptors and then produces prolonged suppression of pituitary gonadotropins. This ultimately lowers sex-hormone production.

3. Is Lupride Depot 3.75mg Injection given every month?

The corresponding 3.75-mg monthly depot formulation is administered once every month for certain indications. Your physician determines the appropriate schedule for your condition.

4. Can I administer the injection myself?

No. Depot leuprolide should be prepared and administered by an appropriately trained healthcare professional according to the product instructions.

5. What are common side effects?

Hot flashes, sweating, headache, nausea, dizziness, mood changes, decreased libido, weight changes, and injection-related effects can occur. Tell your healthcare professional about persistent or troublesome symptoms.